The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_002755.3(MAP2K1):c.323G>T (p.Arg108Leu)

CA10603467

280446 (ClinVar)

Gene: MAP2K1
Condition: RASopathy
Inheritance Mode: Autosomal dominant inheritance
UUID: 33491ca8-e49c-4685-80a6-287992b87237
Approved on: 2020-06-25
Published on: 2020-07-01

HGVS expressions

NM_002755.3:c.323G>T
NM_002755.3(MAP2K1):c.323G>T (p.Arg108Leu)
NM_002755.4:c.323G>T
ENST00000307102.9:c.323G>T
ENST00000425818.2:n.834G>T
NC_000015.10:g.66436777G>T
CM000677.2:g.66436777G>T
NC_000015.9:g.66729115G>T
CM000677.1:g.66729115G>T
NC_000015.8:g.64516169G>T
NG_008305.1:g.54905G>T
More

Pathogenic

Met criteria codes 5
PS2 PP2 PP3 PM2 PM6
Not Met criteria codes 2
PM5 PM1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
RASopathy VCEP
The c.323G>T (p.Arg108Leu) variant in MAP2K1 was absent from large population studies (PM2; gnomad.broadinstitute.org). It was observed as a de novo occurrence in 2 probands, one of whom had maternity and paternity confirmed (PS2, PM6; Fulgent Genetics and Baylor Genetics internal data, ClinVar SCV000894927.1). The variant is located in the MAP2K1 gene, which has been defined by the ClinGen RASopathy Expert Panel as a gene with a low rate of benign missense variants and pathogenic missense variants are common (PP2; PMID: 29493581). Computational prediction tools and conservation analysis suggest that the p.Arg108Leu variant may impact the protein (PP3). In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant RASopathy. RASopathy-specific ACMG/AMP criteria applied (PMID:29493581): PS2, PM2, PM6, PP2, PP3.
Met criteria codes
PS2
Observed in 1 de novo occurrence with parental confirmation (Fulgent Genetics internal data).
PP2
MAP2K1 is a missense-constrained gene (PMID:29493581).
PP3
REVEL 0.831. Entirely conserved in UCSC database. Alamut does not predict an impact to splicing.
PM2
Absent from both versions of gnomAD.
PM6
Observed in 1 de novo occurrence without parental confirmation (Baylor Genetics internal data).
Not Met criteria codes
PM5
2 other variants at this codon: 1 LB (Trp), 1 VUS (Gln).
PM1
Does not occur between amino acids 43-61 or 124-134.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.